PP 1.22 – 00120 Suppression of CD4+ T-cell-intrinsic immunity by HIV-1 latency-reversing HDACi
J. Kazmierski,
D. Postmus,
E. Wyler,
C. Fischer,
K. Meixenberger,
L. Loyal,
A. Thiel,
N. Bannert,
M. Landthaler,
C. Goffinet
Affiliations
J. Kazmierski
Institute of Virology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany
D. Postmus
Institute of Virology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany
E. Wyler
Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
C. Fischer
Scientific Genomics Platforms, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
K. Meixenberger
Division of sexually transmitted bacterial pathogens and HIV, Robert Koch Institute, Berlin, Germany
L. Loyal
Si-M/“Der Simulierte Mensch” a Science Framework of Technische Universität Berlin and Charité – Universitätsmedizin Berlin, Berlin, Germany
A. Thiel
Si-M/“Der Simulierte Mensch” a Science Framework of Technische Universität Berlin and Charité – Universitätsmedizin Berlin, Berlin, Germany
N. Bannert
Division of sexually transmitted bacterial pathogens and HIV, Robert Koch Institute, Berlin, Germany
M. Landthaler
Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; IRI Life Sciences, Institute for Biology, Humboldt-Universität zu Berlin, Berlin, Germany
C. Goffinet
Institute of Virology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany